— Know what they know.
Not Investment Advice
Also trades as: IDHC.L (LSE) · $vol 0M

IDGXF OTC

Integrated Diagnostics Holdings plc
1W: -4.0% 1M: -4.0% 3M: +7.0% YTD: -22.1% 1Y: +11.2% 3Y: -39.6%
$0.53
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 42 · $307.8M mcap · 293M float · 0.0001% daily turnover · Short 97% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.6B +188.5% ▲
5Y CAGR: +17.6%
Capital Expenditures
$225M +31.1% ▲
5Y CAGR: +0.6%
Free Cash Flow
$1.3B +517.3% ▲
5Y CAGR: +22.9%
Dividends Paid
$27M +0.0% ▲
Buybacks
$374M +0.0% ▲
Net Change in Cash
$514M +1896.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$969M$2.2B$854M$737M$1.4B
Depreciation & Amort.$185M$239M$317M$401M$483M
Stock-Based Comp.-$3M-$866K-$8M-$7M$5M
Change in Working Capital-$106M$118M-$250M-$388M-$33M
Other Non-Cash Items$18M$5M-$704M-$200M-$325M
Operating Cash Flow$883M$2.3B$209M$544M$1.6B
— Investing Activities —
Capital Expenditures-$126M-$264M-$309M-$323M-$209M
Acquisitions (Net)$49M$10M$0$0$0
Investment Purchases-$112M-$1.6B-$1.3B-$244M-$859M
Investment Sales$57M$417M$2.5B$250M$494M
Other Investing$8M$108M$106M$73M$128M
Investing Cash Flow-$124M-$1.3B$990M-$244M-$447M
— Financing Activities —
Net Debt Issuance-$14M$5M-$82M-$244M$150M
Stock Repurchased$0$0$0$0-$374M
Dividends Paid-$442M-$479M-$1.4B$0-$27M
Other Financing-$108M-$173M-$123M-$86M-$497M
Financing Cash Flow-$564M-$647M-$1.6B-$330M-$749M
Net Change in Cash$191M$291M-$243M$26M$514M
Cash End of Period$600M$891M$649M$674M$1.2B
Free Cash Flow$757M$2.0B-$100M$218M$1.3B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms